Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Debt (2017 - 2022)

Inspire Medical Systems' Non-Current Debt history spans 6 years, with the latest figure at $9.8 million for Q2 2022.

  • For Q2 2022, Non-Current Debt fell 55.07% year-over-year to $9.8 million; the TTM value through Jun 2022 reached $9.8 million, down 55.07%, while the annual FY2021 figure was $15.8 million, 36.16% down from the prior year.
  • Non-Current Debt for Q2 2022 was $9.8 million at Inspire Medical Systems, down from $12.8 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $24.9 million in Q4 2018 and bottomed at $9.8 million in Q2 2022.
  • The 5-year median for Non-Current Debt is $24.4 million (2019), against an average of $22.0 million.
  • The largest annual shift saw Non-Current Debt surged 51.43% in 2018 before it crashed 55.07% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $24.9 million in 2018, then dropped by 1.62% to $24.5 million in 2019, then increased by 0.91% to $24.7 million in 2020, then plummeted by 36.16% to $15.8 million in 2021, then plummeted by 38.0% to $9.8 million in 2022.
  • Per Business Quant, the three most recent readings for INSP's Non-Current Debt are $9.8 million (Q2 2022), $12.8 million (Q1 2022), and $15.8 million (Q4 2021).